Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 20;7(6):737-738.
doi: 10.1002/mdc3.12985. eCollection 2020 Aug.

Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19

Affiliations

Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19

Filomena Abate et al. Mov Disord Clin Pract. .
No abstract available

Keywords: COVID‐1; DBS; LCIG; Parkinson's disease.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Home program for stimulation tuning with remote control and stimulation management to avoid further hospital visits. Upper section. Pre‐established 4‐week program for stimulation tuning and dopaminergic medication management. Medications were slowly titrated since the patient was at risk for side effects from dopaminergic deprivation given the history of pathological gambling. Medications at the beginning included: Levodopa/Carbidopa/Entacapone 100 mg 2/die, Levodopa/Carbidopa/Entacapone 75 mg 3/die, Levodopa/Carbidopa/Entacapone 50 mg 1/die, Rotigotine patch 4 mg/die, Melevodopa/Carbidopa 100+25 3/die, Amantadine 100 mg 3/die. Lower section. Effective program was changed due to emergence of dyskinesia, increase of sexual drive and gait freezing. Over four weeks, the patient was able to finish programming [R STN C+ (2/3/4)‐ 1.3mA/60μs/130Hz; L STN C+ (5/6/7)‐ 1.3mA/60μs/130Hz) with a significant reduction of levodopa equivalent daily dose (LEDD from 1152 to 600 mg). Amantadine was unmodified. Motor symptoms were monitored with patients’ on‐off diaries. L STN, left subthalamic nucleus; LEDD, levodopa equivalent daily dose; Med, medications; R STN, right subthalamic nucleus; Stim: stimulation.

References

    1. Fasano A, Antonini A, Katzenschlager R, et al. Management of advanced therapies in Parkinson's disease patients in times of humanitarian crisis: the COVID‐19 experience. Mov Disord Clin Pract. 2020;7(4):361–372. - PMC - PubMed
    1. International Parkinson and Movement Disorder Society, Telemedicine Study Group. Telemedicine in your movement disorders practice. https://www.movementdisorders.org/MDS/About/Committees--Other-Groups/Tel.... Published Accessed on June 10, 2020.
    1. Jitkritsadakul O, Rajalingam R, Toenjes C, Munhoz RP, Fasano A. Tele‐health for patients with deep brain stimulation: the experience of the Ontario Telemedicine Network. Mov Disord 2018;33(3):491–492. - PubMed
    1. Picillo M, Lozano AM, Kou N, Puppi Munhoz R, Fasano A. Programming deep brain stimulation for Parkinson's disease: the Toronto Western Hospital Algorithms. Brain Stimul 2016;(9):425–437. - PubMed
    1. Bally JF, Rohani M, Ruiz‐Lopez M, et al. Patient‐adjusted deep‐brain stimulation programming is time saving in dystonia patients. J Neurol 2019;266(10):2423–2429. - PubMed

LinkOut - more resources